The US is about to get a healthy dose of British tech as Medopad announces its expansion into the heart of the country's complex healthcare system. Founded in 2011, the UK-headquartered company creates mobile apps that track patients' wellbeing and can also analyse data from wearable devices. The healthtech company has announced it will be taking up a new office in the heart of New York City at Johnson & Johnson's (J&J's) new JLABS office. As part of the launch, Medopad will hire top healthtech talent before the end of the year. New York City is an established nucleus for the life sciences industry, home to the largest concentration of academic institutions in the world, making it an ideal launchpad into the US. Furthermore, New York boasts the largest workforce in bioscience across the country working at more than 120 companies. "We are thrilled to open a base in the USA as part of Johnson & Johnson's incubator platform JLABS," said Medopad CEO Dan Vahdat.